Benzinga | Oct 12, 2021 06:44AM EDT

Bernstein Initiates Coverage On BeiGene with Outperform Rating, Announces Price Target of $431

Bernstein initiates coverage on BeiGene (NASDAQ:BGNE) with a Outperform rating and announces Price Target of $431.